News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dalal Anupam
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2022 |
4
| Dalal Anupam (Director) has filed a Form 4 on Aadi Bioscience, Inc.|
Txns:
| Granted 320,000 shares
@ $12.5, valued at
$4M
|
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Dalal Anupam (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 7,400 shares
@ $1.52, valued at
$11.2k
|
|
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/26/2020 |
4
| Dalal Anupam (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 52,144 options to buy
@ $1.22, valued at
$63.6k
|
|
| 06/19/2019 |
4
| Dalal Anupam (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 21,400 options to buy
@ $0.96, valued at
$20.5k
|
|
| 06/22/2018 |
4
| Dalal Anupam (Director) has filed a Form 4 on Aerpio Pharmaceuticals, Inc.|
Txns:
| Granted 21,400 options to buy
@ $4, valued at
$85.6k
|
|
| 02/14/2018 |
5
| Dalal Anupam (Director) has filed a Form 5 on Aerpio Pharmaceuticals, Inc. |
| 03/17/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 06/20/2016 |
4
| Dalal Anupam (Director) has filed a Form 4 on Akebia Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $8.56, valued at
$107k
|
|
|
|